Stock BMRA BIOMERICA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Biomerica, Inc. Share Price

Equities

BMRA

US09061H3075

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 21:30:01 26/04/2024 BST 		5-day change 1st Jan Change
0.6652 USD -1.50% Intraday chart for Biomerica, Inc. -8.91% -46.78%
04-15 Biomerica Provides Update on inFoods IBS Expansion CI
04-12 Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 CI

Financials

Sales 2022 18.87M 1.51B Sales 2023 5.34M 426M Capitalization 23.05M 1.84B
Net income 2022 -4M -319M Net income 2023 -7M -559M EV / Sales 2022 2.14 x
Net cash position 2022 4.54M 362M Net cash position 2023 8.64M 690M EV / Sales 2023 2.7 x
P/E ratio 2022
-9.72 x
P/E ratio 2023
-2.72 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 92.7%
More Fundamentals * Assessed data

Chart Biomerica, Inc.

Dynamic Chart

Latest news about Biomerica, Inc.

Biomerica Provides Update on inFoods IBS Expansion CI
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 CI
Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board CI
Biomerica, Inc. Appoints Jack Kenny as Chairman of the Board of Directors CI
Biomerica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023 CI
Top Premarket Decliners MT
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test DJ
Biomerica, Inc. Receives US FDA 510(k) Clearance for their Hp Detect Stool Antigen ELISA Test Product Designed to Detect Presence of H. Pylori Bacteria CI
Biomerica, Inc. Expands in Foods IBS Reach with Addition of Several New GI Groups CI
Biomerica, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023 CI
Biomerica Says Dubai Approves Insurance Reimbursement for Colorectal Disease Screening Test MT
Jack Kenny Joins Biomerica?S Board of Directors CI
Biomerica, Inc. Reports Earnings Results for the Full Year Ended May 31, 2023 CI
Biomerica's Colorectal Disease Screening Test to be Available in CVS Stores in September MT
Biomerica, Inc.(NasdaqCM:BMRA) dropped from Russell 3000E Index CI
More news

Analyst Recommendations on Biomerica, Inc.

BIOMERICA : B. Riley Adjusts Biomerica's Price Target to $10 from $11, Keeps Buy Rating MT
BIOMERICA : Colliers Starts Biomerica at Buy With $13 Price Target MT
More recommendations

Press releases Biomerica, Inc.

Biomerica Reports Third Quarter 2024 Financial Results AQ
Biomerica provides update on inFoods® IBS expansion AQ
Biomerica Reports Third Quarter 2024 Financial Results AQ
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference AQ
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board AQ
More press releases

Quotes and Performance

1 day-1.50%
1 week-8.91%
Current month-20.05%
1 month-20.05%
3 months-26.45%
6 months-36.04%
Current year-46.78%
More quotes

Highs and lows

1 week
0.66
Extreme 0.66
0.80
1 month
0.66
Extreme 0.66
0.91
Current year
0.66
Extreme 0.66
1.35
1 year
0.66
Extreme 0.66
2.13
3 years
0.66
Extreme 0.66
7.38
5 years
0.66
Extreme 0.66
23.39
10 years
0.00
Extreme 0
23.39
More quotes

Managers and Directors - Biomerica, Inc.

Managers TitleAgeSince
Zackary Irani CEO
 Chief Executive Officer 58 31/12/85
Gary Lu DFI
 Director of Finance/CFO 43 28/02/23
Robert Carlson PRN
 Corporate Officer/Principal - 29/08/22
Members of the board TitleAgeSince
Zackary Irani CEO
 Chief Executive Officer 58 31/12/85
Allen Barbieri BRD
 Director/Board Member 65 30/09/99
Jane Emerson BRD
 Director/Board Member 70 31/03/07
More insiders

Quotes

Date Price Change Volume
26/04/24 0.6652 -1.50% 95,316
25/04/24 0.6754 -5.28% 123,066
24/04/24 0.713 -1.25% 660,148
23/04/24 0.722 -0.37% 48,550
22/04/24 0.7247 -0.77% 59,331

Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm

More quotes

Company Profile

Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.
Sector
Medical Equipment, Supplies & Distribution
Calendar
28/08/2024 - Q4 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BIOMERICA, INC. Stock Biomerica, Inc.
-46.78% 11.19M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. BMRA Stock